Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01736280 · ClinicalTrials.gov registry record · NA
Evaluating and Treating Potential Research Participants With Digestive Disorders
A NA study, sponsored by National Institute of Nursing Research (NINR).
- Terminated
- Registry status
- NA
- Development phase
- 225
- Enrollment target
NCT01736280: Clinical Trial NA study, sponsored by National Institute of Nursing Research (NINR).
NCT01736280 is a NA study that was terminated before completion, run by National Institute of Nursing Research (NINR). The registered enrollment target is 225 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01736280, a NA study, was terminated before completion, sponsored by National Institute of Nursing Research (NINR).
- TERMINATED
- Registry status
- NA
- Development phase
- 225 participants
- Enrollment target
Study Summary
Background: \- Some research studies focus on digestive disorders, such as nutritional, gastrointestinal, and liver disorders. Researchers want to examine and treat people with digestive disorders in order to learn more about these disorders. They also want to study how digestive disorders run in some families. To do so, they will provide standard care to people with digestive disorders. They will also look at relatives of people with digestive disorders, such as parents, children, and siblings. Objectives: * To examine and treat people with digestive disorders. * To evaluate people with digestive disorders for research studies. Eligibility: * Individuals of any age who have digestive disorders. * Individuals at least 2 years of age who are first-degree relatives of the people with digestive disorders. Design: * Participants will have at least one outpatient visit to the National Institutes of Health. The visit will last about 2 hours. * All participants will be screened with a physical exam and medical history. They will also provide different samples for study. Samples may include blood, urine, and stool samples. Saliva and hair samples may also be taken. Skin biopsies and rectal swabs may be collected from adult participants. * Participants with digestive disorders may be able to receive treatment through this study.
Primary Outcome
This protocol allows NINR investigators to provide treatment for GI disorders and maintain knowledge and expertise of GI disorders.
Interventions
- OTHER Standard of Care
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 225 participants |
| Start Date | 2012-09-17 |
| Est. Completion | 2019-11-21 |
| Phase | NA |
Why NCT01736280 stopped before completion
NCT01736280 is an interventional study that assigns participants to a tested intervention. The registered 225 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower).
The record links to 0 conditions, and to 1 intervention - of which Standard of Care is the first listed.
NCT01736280 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01736280 about?
NCT01736280 is a clinical study titled "Evaluating and Treating Potential Research Participants With Digestive Disorders". Background: \- Some research studies focus on digestive disorders, such as nutritional, gastrointestinal, and liver disorders. Researchers want to examine and treat people with digestive disorders in order to learn more about these disorders. They also want to study how digestive disorders run in s...
What is the current status of trial NCT01736280?
This trial is currently terminated. It is a NA study. The enrollment target is 225 participants. The study started on 2012-09-17. Estimated completion is 2019-11-21.
What interventions are being tested in trial NCT01736280?
The interventions under investigation include: Standard of Care (OTHER).
Who is sponsoring clinical trial NCT01736280?
This trial is sponsored by National Institute of Nursing Research (NINR), which has 46 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01736280's enrollment target sits among peer trials
225 472nd of 2000 higher than 1,523 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03955445 · 225 participants · Phase 3
Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN
- NCT04054310 · 225 participants · NA
Non-Invasive Quantification of Liver Health in NASH (N-QUAN)
- NCT04480554 · 225 participants · Phase 2
Anti-retroviral Therapy, Medications for Opioid Use Disorder, Opioids and HIV Infection - Study 1
- NCT04888104 · 225 participants
Prospective, Multicenter, Case-Control Analysis of the VersaTie Posterior Fixation System to Prevent Proximal Junctional Failure in Long Posterior Spinal Fusion Constructs for Adult Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI